4.3 Article

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

Ahizechukwu C. Eke et al.

Summary: The workshop discussed the impact of drug exposure during pregnancy and lactation on mothers and infants, addressing the gaps in knowledge on drug selection and dosing in these situations. Collaborative efforts were made to define key standards for generating pharmacology data for antiretrovirals in pregnant and lactating women, with a focus on conducting optimal studies for rapid implementation in clinical settings.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Immunology

Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV

Jeremiah D. Momper et al.

Summary: This study evaluated the pharmacokinetics of darunavir and cobicistat during pregnancy, showing significantly lower exposure levels during pregnancy, which may increase the risk of virologic failure and perinatal transmission.
Article Pharmacology & Pharmacy

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

Ahizechukwu C. Eke et al.

Summary: The workshop aimed to define key standards for generating pharmacology data for antiretrovirals for use among pregnant and lactating women, review the antiretroviral product pipeline, describe key gaps for use in low-income and middle-income countries, and identify opportunities for undertaking optimal studies allowing for rapid implementation in the clinical field.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Review Medicine, General & Internal

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review

Gali Pariente et al.

PLOS MEDICINE (2016)

Article Immunology

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women

Alice Stek et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)

Review Obstetrics & Gynecology

Pharmacokinetics of drugs in pregnancy

Maisa Feghali et al.

SEMINARS IN PERINATOLOGY (2015)

Review Pharmacology & Pharmacy

Physiologic and pharmacokinetic changes in pregnancy

Maged M. Costantine

FRONTIERS IN PHARMACOLOGY (2014)

Article Pharmacology & Pharmacy

Induction of Hepatic CYP3A Enzymes by Pregnancy-Related Hormones: Studies in Human Hepatocytes and Hepatic Cell Lines

Ioannis Papageorgiou et al.

DRUG METABOLISM AND DISPOSITION (2013)

Article Immunology

Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy

Mark Mirochnick et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)

Review Biochemistry & Molecular Biology

Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes

Hyunyoung Jeong

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)

Article Immunology

Reduced lopinavir exposure during pregnancy

Alice M. Stek et al.

Article Obstetrics & Gynecology

Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy

TS Tracy et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)

Article Medical Laboratory Technology

Safety and pharmacokinetics of antiretroviral therapy during pregnancy

NY Rakhmanina et al.

THERAPEUTIC DRUG MONITORING (2004)

Review Pharmacology & Pharmacy

Pharmacokinetics of antiretrovirals in pregnant women

M Mirochnick et al.

CLINICAL PHARMACOKINETICS (2004)